Mari Raffrup
Analyst
Jeffries
Equibles does not estimate personal net worth.
About Mari Raffrup
Mari Raffrup is recorded as Analyst at Jeffries. Mari Raffrup has spoken on 1 earnings call across 1 company, most recently for Karyopharm Therapeutics Inc. on February 12, 2026. The companies whose calls Mari Raffrup spoke on are classified in the Healthcare sector.
Mari Raffrup on recent calls
“Maybe as a follow-up to one of the earlier ones, for the 61 patients in the futility analysis group in Century, what can you say about dose reductions you saw for Selenex and or Ruxolitinib?”
Affiliation history
-
Jeffries
Analyst
Transcript header (unverified)
Current